Low dose oral glucocorticoid therapy in lichen planus: A retrospective cohort study
Indian Journal of Dermatology, Venereology and Leprology · 2022
DOI: 10.25259/ijdvl_1111_2021 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2022. Verfasst von Kamilla Koszorú und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology, and Dermatooncology, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Lichen Planus, Oral, Lichen Planus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
There are various topical and systemic treatment options for the management of lichen planus. However, it is often difficult to achieve long-term disease control and many of the common therapies may be associated with unwanted side effects.
Aims
To evaluate the effectiveness of 8 mg oral methylprednisolone administered daily in lichen planus by the analysis of medical records.
Methods
In this retrospective cohort study, we compared the rates of improvement between two groups of patients. The first group received 8 mg oral methylprednisolone daily for at least one month. In the second group, patients with similar parameters to the first group (age, sex, disease manifestation) but without systemic glucocorticoid therapy were included. Fisher’s exact test was used to compare the rates of remission in the two groups.
Results
In the daily oral methylprednisolone ( n = 24) and no systemic corticosteroids ( n = 16) groups, 23 (95.8%) and 6 (37.5%) patients achieved partial or complete remission, respectively. The frequency of improvement was significantly higher in patients who received oral methylprednisolone ( P < 0.0001).
Limitations
Limitations of this study include its retrospective design and the relatively small sample size.
Conclusion
Low dose oral glucocorticoid therapy may be an effective option for the systemic treatment of lichen planus. Based on our results and previous studies, instead of higher doses, longer therapy duration with low doses should be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology, and Dermatooncology, Semmelweis University, Budapest, Hungary.
Zitieren
APA
Koszorú, K., Kovács, A., Lőrincz, K., Medvecz, M., & Sárdy, M. (2022). Low dose oral glucocorticoid therapy in lichen planus: A retrospective cohort study. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_1111_2021
Vancouver
Koszorú K, Kovács A, Lőrincz K, Medvecz M, Sárdy M. Low dose oral glucocorticoid therapy in lichen planus: A retrospective cohort study. Indian Journal of Dermatology, Venereology and Leprology. 2022. doi:10.25259/ijdvl_1111_2021
BibTeX
@article{Koszor2022,
author = {Koszorú, Kamilla and Kovács, Anikó and Lőrincz, Kende and Medvecz, Márta and Sárdy, Miklós},
title = {Low dose oral glucocorticoid therapy in lichen planus: A retrospective cohort study},
journal = {Indian Journal of Dermatology, Venereology and Leprology},
year = {2022},
doi = {10.25259/ijdvl_1111_2021}
}
EUVIMED